Primary and secondary outcome measures

BMJ (Online)

Volumn 340, Issue 7751, 2010, Pages 873-

  Sedgwick, Philip ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANE; ALKANE VAPOCOOLANT SPRAY; PLACEBO; UNCLASSIFIED DRUG;

CANNULATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; NOTE; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL;

EID: 77951079133     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c1938     Document Type: Note

References (1)

1. Hijazi R, Taylor D, Richardson J. Effect of topical alkane vapocoolant spray on pain with intravenous cannulation in patients in emergency departments: randomised double blind placebo controlled trial. BMJ 2009;338:b215.[Abstract/ Free Full Text]